Crexavibart Biosimilar
REQUEST MORE INFO
Catalogue No: abx831961
Price:
US$435.00
(Size: 100 µg)
Orders to United States ship from United States
(
Click on the image to see the image legend
Add to Cart
Buy It Now
GET A QUOTE
Documents
Datasheet SDS
Crexavibart is a monoclonal antibody biosimilar expressed in Mammalian cells, targeting SARS-CoV-2 (2019-nCoV)Spike glycoprotein, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Research Articles on Spike glycoprotein
| Target | Spike glycoprotein |
| Clonality | Monoclonal |
| Reactivity | Virus |
| Expression | Recombinant |
| Host | Human |
| Isotype | IgG1 Lambda2 |
| Form | Liquid |
| Purity | > 95% (SDS-PAGE) |
| Purification | Purified from cell culture supernatant by protein A/G chromatography. |
| Storage | Store at 4°C for up to 2 weeks. Aliquot and store at -20°C for long term storage. Avoid repeated freeze/thaw cycles. |
| Shelf Life | 12 months. |
| Buffer | 0.01 M PBS, pH 7.4. |
| CAS Number | 2599039-61-7 |
| Availability | Shipped within 5-12 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |